CRPS/RSD Community Recognizes Leader in Pain Management

Recently, the American Society of Regional Anesthesia and Pain Medicine selected Dr. Michael Stanton-Hicks as its 2017 John J. Bonica Lecture Award winner. Having been called a giant in the management of complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD) because of his extensive contributions to…

Read More

North Carolina Teen Beats CRPS/RSD: Next Stop, NFL

When 15-year-old Nazair (Naz) Jones woke up on November 5, 2011, he could not move. Then after years of persistent pain, complete loss of control of the use of his limbs, and the loss of 50 pounds, the once-healthy, gifted athlete was diagnosed with complex…

Read More

Traveling With CRPS/RSD? Plan Ahead

Thinking of taking a trip overseas? For those who suffer from complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD), this can be a painful proposition. Extended travel is particularly difficult for those dealing with chronic pain, given the shrinking legroom and lack of flexibility airline seats…

Read More

CRPS/RSD Difficult to Diagnose, Harder to Live With

Articles surrounding complex regional pain syndrome/reflex sympathetic dystrophy (CRPS/RSD) often describe the disorder as “painful,” “misunderstood,” and “difficult to treat” for one very important reason: like fibromyalgia, low back pain, or even a simple headache, CRPS/RSD is a human condition without reliable animal models, and…

Read More

Pain Drug Reaches Phase 3 Clinical Trials

A Pittsburg-based drug development company has received U.S. Food and Drug Administration (FDA) approval for phase 3 clinical trials of a product to treat severe, persistent pain. The medication, T-121, is being developed by Thar Pharmaceuticals and is expected to enter the market by 2019.…

Read More